The Catalytic Domain of Protein Kinase C Chimeras Modulates the Affinity and Targeting of Phorbol Ester-induced Translocation

Péter Ács, Krisztina Bögi, Patricia S. Lorenzo, Adriana M. Marquez, Tamás Bı́ró, Zoltán Szállási, Peter M. Blumberg

Journal of Biological Chemistry · 1997 · 39 citations · 28 references

DOIFull text

Open access

Concepts

Abstract

Emerging evidence suggests important differences among protein kinase C (PKC) isozymes in terms of their regulation and biological functions. PKC is regulated by multiple interdependent mechanisms, including enzymatic activation, translocation of the enzyme in response to activation, phosphorylation, and proteolysis. As part of our ongoing studies to define the factors contributing to the specificity of PKC isozymes, we prepared chimeras between the catalytic and regulatory domains of PKCα, -δ, and -ε. These chimeras, which preserve the overall structure of the native PKC enzymes, were stably expressed in NIH 3T3 fibroblasts. Their intracellular distribution was similar to that of the endogenous enzymes, and they responded with translocation upon treatment with phorbol 12-myristate 13-acetate (PMA). We found that the potency of PMA for translocation of the PKCα/x chimeras from the soluble fraction was influenced by the catalytic domain. The ED50 for translocation of PKCα/α was 26 nm, in marked contrast to the ED50 of 0.9 nm in the case of the PKCα/ε chimera. In addition to this increase in potency, the site of translocation was also changed; the PKCα/ε chimera translocated mainly into the cytoskeletal fraction. PKCx/ε chimeras displayed twin isoforms with different mobilities on Western blots. PMA treatment increased the proportion of the higher mobility isoform. The two PKCx/ε isoforms differed in their localization; moreover, their localization pattern depended on the regulatory domain. Our results emphasize the complex contributions of the regulatory and catalytic domains to the overall behavior of PKC. Emerging evidence suggests important differences among protein kinase C (PKC) isozymes in terms of their regulation and biological functions. PKC is regulated by multiple interdependent mechanisms, including enzymatic activation, translocation of the enzyme in response to activation, phosphorylation, and proteolysis. As part of our ongoing studies to define the factors contributing to the specificity of PKC isozymes, we prepared chimeras between the catalytic and regulatory domains of PKCα, -δ, and -ε. These chimeras, which preserve the overall structure of the native PKC enzymes, were stably expressed in NIH 3T3 fibroblasts. Their intracellular distribution was similar to that of the endogenous enzymes, and they responded with translocation upon treatment with phorbol 12-myristate 13-acetate (PMA). We found that the potency of PMA for translocation of the PKCα/x chimeras from the soluble fraction was influenced by the catalytic domain. The ED50 for translocation of PKCα/α was 26 nm, in marked contrast to the ED50 of 0.9 nm in the case of the PKCα/ε chimera. In addition to this increase in potency, the site of translocation was also changed; the PKCα/ε chimera translocated mainly into the cytoskeletal fraction. PKCx/ε chimeras displayed twin isoforms with different mobilities on Western blots. PMA treatment increased the proportion of the higher mobility isoform. The two PKCx/ε isoforms differed in their localization; moreover, their localization pattern depended on the regulatory domain. Our results emphasize the complex contributions of the regulatory and catalytic domains to the overall behavior of PKC. Protein kinase C (PKC) 1The abbreviations used are: PKC, protein kinase C; PMA, phorbol 12-myristate 13-acetate; PCR, polymerase chain reaction; PDBu, phorbol 12,13-dibutyrate.is a major family of serine/threonine kinases that plays a crucial role in cell signal transduction, regulating cell growth and differentiation (1Nishizuka Y. Science. 1992; 258: 607-614Crossref PubMed Scopus (4230) Google Scholar). Emerging evidence suggests important differences among PKC isozymes both in their regulation and in their biological roles. Thus, in K-562 erythroleukemia cells, PKCα was implicated in mediating PMA-induced cytostasis, whereas PKCβII was involved in proliferation (2Murray N.R. Baumgardner G.P. Burns D.J. Fields A.P. J. Biol. Chem. 1993; 268: 15847-15853Abstract Full Text PDF PubMed Google Scholar). In RBL-2H3 basophilic leukemia cells, the PKCα and -ε isoforms preferentially inhibited phospholipase C activity (3Ozawa K. Szallasi Z. Kazanietz M.G. Blumberg P.M. Mischak H. Mushinski J.F. Beaven M.A. J. Biol. Chem. 1993; 268: 1749-1756Abstract Full Text PDF PubMed Google Scholar), whereas the PKCβ and -ε isoforms linked the mast cell high affinity receptor for IgE to the expression of c-fos and c-jun (4Razin E. Szallasi Z. Kazanietz M.G. Blumberg P.M. Rivera J. Proc. Natl. Acad. Sci. U. S. A. 1994; 91: 7722-7726Crossref PubMed Scopus (64) Google Scholar). In PKCβ knockout mice, signaling through the antigen receptor-dependent signaling pathway was markedly impaired (5Leitges M. Schmedt C. Guinamard R. Davoust J. Schaal S. Stabel S. Tarakhovsky A. Science. 1996; 273: 788-791Crossref PubMed Scopus (414) Google Scholar). Not only may some PKC isoforms be active whereas others not for a given response, but the actions of different isoforms may even be antagonistic. In NIH 3T3 cells, for example, PKCδ arrested cell growth, whereas PKCε stimulated it (6Mischak H. Goodnight J.A. Kolch W. Martiny-Baron G.M. Schaechtle C. Kazanietz M.G. Blumberg P.M. Pierce J.H. Mushinski J.F. J. Biol. Chem. 1993; 268: 6090-6096Abstract Full Text PDF PubMed Google Scholar, 7Cacace A.M. Guadagno S.N. Krauss R.S. Fabbro D. Weinstein I.B. Oncogene. 1993; 8: 2095-2104PubMed Google Scholar). As part of our ongoing studies to explore the basis of specificity of PKC isozymes, we have prepared chimeras between the regulatory and the catalytic domains of PKCα, -δ, and -ε and investigated their behavior in intact cells. Protein kinase C consists of an N-terminal regulatory domain and a C-terminal catalytic domain. The catalytic domain acts as a serine/threonine-specific protein kinase, and the regulatory domain is thought to inhibit this catalytic activity through a so-called pseudosubstrate region near its N terminus. Immediately C-terminal to this pseudosubstrate region is a pair of highly conserved zinc finger structures termed the C1 domains that are the sites of phorbol ester binding on the molecule and contribute to the association with anionic phospholipid (8Burns D.J. Bell R.M. J. Biol. Chem. 1991; 266: 18330-18338Abstract Full Text PDF PubMed Google Scholar, 9Hurley J.H. Newton A.C. Parker P.J. Blumberg P.M. Nishizuka Y. Protein Sci. 1997; 6: 477-480Crossref PubMed Scopus (320) Google Scholar). In the classic isozymes, α, βI, βII, and γ, a second domain in the regulatory region, the C2 domain, bestows Ca2+ dependence. The novel isozymes, δ, ε, η, and θ, lack this region and correspondingly lack Ca dependence, although they have a modified C2 homolog N-terminal to the C1 domain (10Sossin W.S. Schwartz J.H. Trends Biochem. Sci. 1993; 18: 207-208Abstract Full Text PDF PubMed Scopus (61) Google Scholar). The individual C1 domains of PKC bind phorbol esters with similar affinity to the intact PKC. X-ray crystallography of the PKCδ C1b domain revealed that the phorbol ester inserts into a hydrophilic cleft in an otherwise hydrophobic surface, promoting interaction of the C1 domain with the membrane (11Zhang G. Kazanietz M.G. Blumberg P.M. Hurley J.H. Cell. 1995; 81: 917-924Abstract Full Text PDF PubMed Scopus (600) Google Scholar). It thus functions as a hydrophobic switch. In the intact unstimulated cell, PKC is largely cytosolic with some proportion depending on the isoform and the cell type present in the membrane and cytoskeletal fractions (12Szallasi Z. Smith C.B. Pettit G.R. Blumberg P.M. J. Biol. Chem. 1994; 269: 2118-2124Abstract Full Text PDF PubMed Google Scholar, 13Szallasi Z. Denning M.F. Smith C.B. Dlugosz A.A. Yuspa S.H. Pettit G.R. Blumberg P.M. Mol. Pharmacol. 1994; 46: 840-850PubMed Google Scholar). Phorbol ester addition leads to translocation of PKC from the cytosol to the membranes, presumably reflecting enhanced membrane affinity of the C1-phorbol ester complex. This translocation provides one measure of the response of specific PKC isoforms in the context of the intact cell. Emerging understanding suggests that translocation should not only depend on the strength of the association between the C1 domain and the membrane but should also be coupled to other factors contributing to the membrane association and the energetics of conformational changes in the enzyme upon activation. Receptors for activated protein kinase C, the binding proteins for the regulatory domain of PKC, have been described (14Mochly-Rosen D. Khaner H. Lopez J. Proc. Natl. Acad. Sci. U. S. A. 1991; 88: 3997-4000Crossref PubMed Scopus (441) Google Scholar), which stabilize the activated conformation of the enzyme (15Mochly-Rosen D. Science. 1995; 268: 247-251Crossref PubMed Scopus (834) Google Scholar). Specific substrates likewise can drive association, as elegantly shown by Jaken and co-workers (16Chapline C. Mousseau B. Ramsay K. Duddy S. Li Y. Kiley S.C. Jaken S. J. Biol. Chem. 1996; 271: 6417-6422Abstract Full Text Full Text PDF PubMed Scopus (71) Google Scholar). The state of phosphorylation of PKC is another important regulator that influences both activity and localization (17Newton A.C. J Biol. Chem. 1995; 270: 28495-28498Abstract Full Text Full Text PDF PubMed Scopus (1471) Google Scholar,18Dutil E.M. Keranen L.M. DePaoli-Roach A.A. Newton A.C. J. Biol. Chem. 1994; 269: 29359-29362Abstract Full Text PDF PubMed Google Scholar). Finally, the ability of the pseudosubstrate domain to interact with the catalytic domain is central to its function. We report here that the catalytic domain of PKC influences both the potency of phorbol ester for PKC translocation and the compartment to which PKC is translocated in response to phorbol ester. Protein kinase C chimeras were generated by swapping the regulatory and the catalytic domains of PKCα, PKCδ, and PKCε. The regulatory domain of PKCε was amplified by polymerase chain reaction (PCR) employing high fidelity thermostable vent DNA polymerase using the following primers: 5′-CTCGAGATGGTAGTGTTCAATGGCCTTCTTA-3′ and 5′-GCTGCCTTTGACTAGTACCTTGAT-3′. To amplify the catalytic domain of PKCε, the primers we used were: 5′-GTACTAGTCAAAGGCAGCTTTGGCAA-3′ and 5′-GACGCGTTCAGGGCATCAGGTCTTCACCAAA-3′. The regulatory and catalytic domains of PKCδ were amplified by utilizing the primers below, respectively: 5′-GGGCTCGAGATGGCACCCTTCCTTCGCATTT-3′, 5′-GCTGCCTTTGACTAGTACTTTT-3′, 5′-GTACTAGTCAAAGGCAGCTTTGGCAA-3′, and 5′-CCACGCGTAATGTCCAGGAATTGCTCAAACTT-3′. To amplify the regulatory and catalytic domains of PKCα, we employed the following primers, respectively: 5′-CGCTCGAGATGGCTGACGTCTTCC-3′, 5′-GCTGCCTTTGACTAGTACCATGAGGAA-3′, 5′-GTACTAGTCAAAGGCAGCTTTGGCAA-3′, and 5′-CGACGCGTTACCGCGCTCTGCAGGATGG-3′. To reduce the chance of introducing mutations, we not only used high fidelity enzymes but we also kept the number of PCR cycles low (8 cycles). To facilitate subsequent cloning steps, into the inner PCR primers we introduced a unique restriction site (SpeI). After 8 cycles of polymerase chain reaction, we added an adenine overhang to the constructs withTaq polymerase at 72 °C after removing the primers, and we then ligated them into the pGEM-T vector. From this point on we employed only classical cloning techniques to further reduce the possibility of mutations in our constructs. Using the pGEM-T vector as a shuttle vector we amplified the different PKC domains by them into we then the catalytic domains into the the regulatory domains and restriction important of this is that we the type PKCα, -δ, and -ε isoforms using the inserts as for the chimeras, with type the as the we to the site to the using the following primers: for chimeras with PKCα regulatory domain, for chimeras with PKCδ regulatory domain, and for with PKCε regulatory domain, We used the site for the The chimeras with the type PKC isozymes were then into an expression vector described in by Z. C. G. Biochem. 1994; PubMed Scopus Google Scholar). The and sites and the vector a C-terminal to the of the from the C of PKCε. Finally, our constructs were by to that mutations been The chimeras were as and to the regulatory and the catalytic Thus, for example, to the chimera between the regulatory domain and the catalytic domain. NIH 3T3 were in modified with and The were with the vector the different PKC expression using following the by the The were in After in were and for the of different PKC chimeras by Western were with different of PMA for and at was added to the cells. were on of cells, but results were on individual The were into and and by The cytosolic fraction the following at for at The soluble fraction was prepared by a of the with the and a subsequent for at The is the fraction. The were to to PubMed Scopus Google and to The protein of individual was (12Szallasi Z. Smith C.B. Pettit G.R. Blumberg P.M. J. Biol. Chem. 1994; 269: 2118-2124Abstract Full Text PDF PubMed Google by the Western with in The protein was found to be to of The was by with the were with in and with generated a to of PKCε In some the chimeras the and the catalytic domains were with the domain from and and were coupled to and the were by the Western from The of the and the to the protein of individual were as described (12Szallasi Z. Smith C.B. Pettit G.R. Blumberg P.M. J. Biol. Chem. 1994; 269: 2118-2124Abstract Full Text PDF PubMed Google Scholar). Protein kinase C activity was by the of from into substrates described M.G. A. Mischak H. Goodnight J. Mushinski J.F. Blumberg P.M. Mol. Pharmacol. 1993; Google in the of and were on a and of the cell were in from of and protein as at °C for The reaction was by at After for at a of the was The were in and in The was by The kinase was with this and at was with the of protein the of cell used in the binding was by using the M.G. A. Mischak H. Goodnight J. Mushinski J.F. Blumberg P.M. Mol. Pharmacol. 1993; Google Scholar). cell of were with nm in the of in the of PDBu, was to specific in We have protein kinase -δ, and -ε chimeras to the contributions of the regulatory and the catalytic of isozymes to their We have that PKC chimeras can be stably expressed in NIH 3T3 cells, bind and kinase activity as the type PKC isozymes Using a described Z. C. G. Biochem. 1994; PubMed Scopus Google we the endogenous and isozymes of PKCα/x and are by the regulatory In the case of and we our by using and the of enzymes as as the of the were higher the endogenous PKCε, by the endogenous PKCε was not a The the two described at and A.M. Guadagno S.N. Krauss R.S. Fabbro D. Weinstein I.B. Oncogene. 1993; 8: 2095-2104PubMed Google of the PKCε. and PKCα/ε chimeras also on Western that the phosphorylation of the PKCε catalytic domain was similar to that of the In the and chimeras a that the of PKCε only on the catalytic binding of PKC binding of the different PKC chimeras was by the described the with of a other similar The for the and the PKCα/α chimera are expressed as of of and the for the other chimeras were further on their of expression to the PKCα/α chimera. in a Specific binding of the different PKC chimeras was by the described the with of a other similar The for the and the PKCα/α chimera are expressed as of of and the for the other chimeras were further on their of expression to the PKCα/α chimera. To explore the role of the catalytic domains in phorbol ester response, we the translocation and localization of the different chimeras after PMA treatment on the of translocation of the endogenous PKCα, -δ, and -ε isoforms in (12Szallasi Z. Smith C.B. Pettit G.R. Blumberg P.M. J. Biol. Chem. 1994; 269: 2118-2124Abstract Full Text PDF PubMed Google we the on the chimeras of treatment with of PMA for and The translocation were after of to PMA, and at this point was not not one using were at The type PKC isozymes and translocated with and similar to of the endogenous enzymes (12Szallasi Z. Smith C.B. Pettit G.R. Blumberg P.M. J. Biol. Chem. 1994; 269: 2118-2124Abstract Full Text PDF PubMed Google Scholar), by the by the were also with at one of similar results to the of the affinity of PMA to translocation of the endogenous PKC isozymes and the PKC isozymes with for the endogenous for the 3T3 with PKC chimeras were by PMA, the soluble fraction was and Western was as described The of the enzyme was by and and ED50 were from the the of at The ED50 for the endogenous are from Z. Smith C.B. Pettit G.R. Blumberg P.M. J. Biol. Chem. 1994; 269: 2118-2124Abstract Full Text PDF PubMed Google in a NIH 3T3 with PKC chimeras were by PMA, the soluble fraction was and Western was as described The of the enzyme was by and and ED50 were from the the of at The ED50 for the endogenous are from Z. Smith C.B. Pettit G.R. Blumberg P.M. J. Biol. Chem. 1994; 269: 2118-2124Abstract Full Text PDF PubMed Google The distribution of PKC chimeras in the is in The distribution of the type enzymes was similar to that for the endogenous enzymes (12Szallasi Z. Smith C.B. Pettit G.R. Blumberg P.M. J. Biol. Chem. 1994; 269: 2118-2124Abstract Full Text PDF PubMed Google that of was found in the fraction. The of distribution in the case of PKCα/x regulatory chimeras was by the regulatory domain. role for the catalytic domain was in the case of moreover, the catalytic domain of PKCε to have some in PKCα/ε and into the fraction was also higher as The distribution differed from that of both isozymes with a higher proportion in the fraction. The of kinase activity was for that of the other chimeras on the other the chimera binding activity differences may be to the higher in the fraction to be localization of PKC chimeras in of distribution of the individual PKC isozymes among the fractions by was on the protein in soluble fraction the soluble fraction and the fraction of the results were in a second of in a The distribution of the individual PKC isozymes among the fractions by was on the protein in soluble fraction the soluble fraction and the fraction of the results were in a second of In the case of the PKCα regulatory chimeras, the catalytic domain markedly influenced the affinity of PMA for the PMA was in the type PKCα/α the and The for the in PKC in the soluble fraction were and to the In the case of type the ED50 for translocation was 26 nm to that for the endogenous PKCα (12Szallasi Z. Smith C.B. Pettit G.R. Blumberg P.M. J. Biol. Chem. 1994; 269: 2118-2124Abstract Full Text PDF PubMed Google It to nm in the case of the chimera and was an of in the case of the PKCα/ε chimera the chimeras the and regulatory domains the ED50 for PMA-induced translocation were similar of the specific regulatory catalytic domain 8 for of PMA-induced translocation of PKC chimeras in NIH 3T3 cells. NIH 3T3 with PKC chimeras were with the soluble fraction was and Western was as described The of the enzyme was by and expressed as the of the of present in the soluble fraction in the cells. were from the and the ED50 are shown in this the of at Not only the PKCα/ε chimera have a that was to the but the of translocation the chimera translocated to the fraction. This in distribution was to a proportion of the PKCα/ε chimera in the as with the to in the PKC The of PKCα/ε was present in the whereas the was in the cytosolic and fractions The and chimeras also revealed a PMA in the of the two with an increase in the at higher PMA The distribution of the two depended on the of the regulatory domain, whereas the of the two depended on the catalytic domain. with and PKCα/ε a proportion of the present in the fraction. of the higher mobility isoform in the cytosolic and membrane We the PMA of the increase in the for the PKCx/ε The ED50 were similar to for the in the soluble fraction nm for 8 nm for and nm for We that the two in major is to the factors regulating the of through the of PKC isoforms present in specific cell isoform it is that in binding to PKC isozymes major contributions to in the intact cells. Thus, phorbol esters have a affinity for PKCε with PKCα in M.G. A. Mischak H. Goodnight J. Mushinski J.F. Blumberg P.M. Mol. Pharmacol. 1993; Google Scholar), whereas PMA is for translocation of PKCε of PKCα in Z. Denning M.F. Smith C.B. Dlugosz A.A. Yuspa S.H. Pettit G.R. Blumberg P.M. Mol. Pharmacol. 1994; 46: 840-850PubMed Google Scholar). moreover, on the specific cell In NIH 3T3 cells, the of PMA for PKCε with PKCα is only the in the (12Szallasi Z. Smith C.B. Pettit G.R. Blumberg P.M. J. Biol. Chem. 1994; 269: 2118-2124Abstract Full Text PDF PubMed Google Scholar, 13Szallasi Z. Denning M.F. Smith C.B. Dlugosz A.A. Yuspa S.H. Pettit G.R. Blumberg P.M. Mol. Pharmacol. 1994; 46: 840-850PubMed Google Scholar). Our results that the factors the phorbol ester depend on the catalytic domain of PKC as as on the phorbol ester binding C1 of the specific by which the catalytic domain to the translocation to be by which the catalytic domain protein kinase C and phorbol ester be through the strength of the interaction between the pseudosubstrate region and the catalytic and co-workers K. A. Z. J. Biol. Chem. 1997; Full Text Full Text PDF PubMed Scopus Google have in the of the PKC The pseudosubstrate similar for the and catalytic was not K. A. Z. J. Biol. Chem. 1997; Full Text Full Text PDF PubMed Scopus Google Scholar). we similar of the PKCα and PKCε for PKCε M.G. A. Mischak H. Goodnight J. Mushinski J.F. Blumberg P.M. Mol. Pharmacol. 1993; Google Scholar). the regulation of PKC isozymes by second and membrane been (1Nishizuka Y. Science. 1992; 258: 607-614Crossref PubMed Scopus (4230) Google Scholar, A.C. 1993; PubMed Scopus Google Scholar), the by which can from receptor active In stimulated with phorbol of the PKC to including the membrane M. J.F. Biochem. PubMed Scopus (71) Google Scholar), (15Mochly-Rosen D. Science. 1995; 268: 247-251Crossref PubMed Scopus (834) Google Scholar), (15Mochly-Rosen D. Science. 1995; 268: 247-251Crossref PubMed Scopus (834) Google Scholar, D. 1994; Google Scholar), and (15Mochly-Rosen D. Science. 1995; 268: 247-251Crossref PubMed Scopus (834) Google Scholar). the cell isozymes may be to different sites after cell D. 1994; Google Scholar, Fields A.P. J. Biol. Chem. 1991; 266: Full Text PDF PubMed Google Scholar). of protein kinases to sites their to substrates (15Mochly-Rosen D. Science. 1995; 268: 247-251Crossref PubMed Scopus (834) Google Scholar). evidence both the regulatory and the catalytic domains in PKC It been that membrane binding of PKC in the binding of the activated enzyme to the for activated protein kinase C D. Biochem. 1992; PubMed Scopus Google Scholar). This the regulatory domain of PKC (14Mochly-Rosen D. Khaner H. Lopez J. Proc. Natl. Acad. Sci. U. S. A. 1991; 88: 3997-4000Crossref PubMed Scopus (441) Google Scholar), the active conformation of the enzyme (15Mochly-Rosen D. Science. 1995; 268: 247-251Crossref PubMed Scopus (834) Google Scholar). Protein kinase was also to bind to through a binding site the regulatory domain R. J. Biol. 1996; PubMed Scopus Google Scholar). is evidence for the role of the catalytic domain in and only at the C they S.C. Jaken S. R. Parker P.J. Biochem. 1995; PubMed Scopus Google Scholar), that unique C-terminal may isoforms to different S.C. Parker P.J. J. Sci. 1995; Google Scholar). using PKCα and chimeras, a region the catalytic domain of PKC was shown to be for its translocation to the N.R. Burns D.J. Fields A.P. Proc. Natl. Acad. Sci. U. S. A. 1995; PubMed Scopus Google Scholar). may also by binding to proteins that as C kinase and chain S.C. Jaken S. R. Parker P.J. Biochem. 1995; PubMed Scopus Google Scholar, C. Mousseau B. Ramsay K. Jaken S. J. Biol. Chem. 1995; 270: Full Text Full Text PDF PubMed Scopus Google Scholar). the membrane association of the PKC regulatory domain, in contrast to the cytosolic localization of the for a role of the catalytic domain S. Biol. 1996; 8: PubMed Scopus Google Scholar). Finally, studies a role for the catalytic domain in the pattern of localization and translocation of PKCδ and PKCε J. J. M. H. J. for other the described here that the catalytic domain can the potency of PMA for Not phosphorylation as an important of PKC regulation (17Newton A.C. J Biol. Chem. 1995; 270: 28495-28498Abstract Full Text Full Text PDF PubMed Scopus (1471) Google Scholar). provides on the so-called of PKC that is for enzymatic activity Newton A.C. J. Biol. Chem. 1994; 269: Full Text PDF PubMed Google Scholar, S. Parker P.J. Biochem. J. 1994; PubMed Scopus Google Scholar). This is by two on the C of the further the active conformation and also the enzyme soluble E.M. Keranen L.M. DePaoli-Roach A.A. Newton A.C. J. Biol. Chem. 1994; 269: 29359-29362Abstract Full Text PDF PubMed Google Scholar). Our studies a role for phosphorylation in the localization of PKCε, with PMA the proportion of the higher mobility isoform of PKCx/ε chimeras in the fraction. the the localization of chimeras depend on the regulatory domain. The that the phosphorylation state of as as PKC chimeras can after PMA treatment that protein may a role in different PMA chimeras that have the regulatory domains but different catalytic domains with that by an of Phorbol esters bind to the C1 domains of PKC a hydrophobic a hydrophilic cleft (11Zhang G. Kazanietz M.G. Blumberg P.M. Hurley J.H. Cell. 1995; 81: 917-924Abstract Full Text PDF PubMed Scopus (600) Google Scholar). the their contribute to the enzyme at the Our results that binding of PMA other that translocation in and that a role in PKC to sites of PKCx/ε chimeras to the

References

28